Madrigal Pharmaceuticals (MDGL) had the highest return in February 2022 by a large-cap US stock, returning 61.3%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Madrigal Pharmaceuticals (MDGL) | February 2022 | 61.31% |
Frontline (FRO) | February 2022 | 43.23% |
Bloom Energy (BE) | February 2022 | 43.04% |
IONQ (IONQ) | February 2022 | 39.93% |
Credo Technology (CRDO) | February 2022 | 39.44% |
Allegheny Technologies (ATI) | February 2022 | 38.39% |
First Horizon (FHN) | February 2022 | 37.39% |
Tower Semiconductor (TSEM) | February 2022 | 35.01% |
Carpenter Technology (CRS) | February 2022 | 32.52% |
Performance Food (PFGC) | February 2022 | 32.51% |
Alcoa (AA) | February 2022 | 29.92% |
Gold Fields Ltd ADR (GFI) | February 2022 | 29.69% |
Coupang LLC (CPNG) | February 2022 | 29.18% |
Nucor (NUE) | February 2022 | 27.28% |
Summit Therapeutics (SMMT) | February 2022 | 26.85% |
Cameco (CCJ) | February 2022 | 24.9% |
Steel Dynamics (STLD) | February 2022 | 24.63% |
Elbit Systems (ESLT) | February 2022 | 23.67% |
Eldorado Gold (EGO) | February 2022 | 23.31% |
Reliance Steel & Aluminum (RS) | February 2022 | 23.05% |
Freeport-McMoran Copper & Gold (FCX) | February 2022 | 22.91% |
Woodside Energy (WDS) | February 2022 | 22.56% |
Globalfoundries (GFS) | February 2022 | 21.97% |
Nutrien (NTR) | February 2022 | 21.76% |
L3Harris Technologies (LHX) | February 2022 | 21.65% |
Large-cap stocks are treated as having a market cap of $10B+.